Falling wedge on Cannabis Testing Company Abattis Bioceuticals

Falling wedge on 60m chart with basing MACD and RSI. For short and long this is a great price for this company, which has been bleeding since peak in january. PENNY STOCK Opp.

Trade active:

Nice 60% climb since first posting and ready to jump another 60% in next month as testing gets ready for medical sales growth and recreational use.

Comment:

Bought half at 0.089 and 2nd half at 0.082 and at 0.152